NCT01318434 · Interventional trial
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Overall registry status Completed
Phase 2 · Phase 3
Conditions Major Depressive Disorder
Delaware Valley sites
- CRI Worldwide · Philadelphia, PA · Philadelphia County
- CRI Worldwide, LLC · Willingboro, NJ · Burlington County
- Southeastern PA Medical Institute · Broomall, PA · Delaware County
- Suburban Research Associates · Media, PA · Delaware County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory